期刊文献+

BSA-PLGA缓释微球制备工艺的优化 被引量:7

Optimization of preparation of BSA-PLGA controlled-release microspheres
下载PDF
导出
摘要 目的:以牛血清白蛋白(BSA)为模型蛋白,乳酸/羟乙酸共聚物(PLGA)为载体,优化微球的制备工艺。方法:采用复乳溶剂挥发法制备BSA-PLGA微球,以包封率、载药量、粒径及24h释放率等为观察指标,通过正交设计法优化显著影响微球制备工艺条件的7种因素。结果:优化后的工艺条件是BSA用量为5mg、PEG用量为0.2mL、PLGA用量为200mg、PVA浓度为1%、NaCl浓度为10%、超声功率为40W、复乳搅拌速度为1000r/min。结论:该制备工艺简单、稳定,可以得到包封率高、粒径适宜、突释较少的BSA-PLGA微球。 Objective To optimize the preparation technique for microspheres using BSA as model protein and PLGA as controlled-release carrier. Methods BSA-PLGA microspheres were prepared using (water-in-oil) in water emulsion solvent evaporation technique. Using entrapment effciency, loading effciency , particle size, and 24 h-release amount as the evaluating indicators, we optimized the 7 factors that markedly influenced the preparation technique for microspheres by orthogonal factorization method. Results The optimized parameters were BSA of 5 rag, PEG of 0.2 mL, PLGA of 200 rag, 1% PVA, 10% NaCl, ultrasonic power of 40 W, and stirring rate of secondary emulsion of 1 000 r·min^-1. Conclusions The preparation technique for BSA-PLGA microspheres is simple and stable, by which we can acquire the microspheres with high entrapment efficiency, low burst release amount, and proper particle size.
出处 《实用医学杂志》 CAS 北大核心 2009年第15期2562-2565,共4页 The Journal of Practical Medicine
基金 浙江省自然科学基金项目(编号:Y2080507) 温州市科技局资助项目(编号:H20080031)
关键词 微球体 血清白蛋白 乳酸盐类 聚合物 药物载体 Microspheres BSA PLGA Polymer Drug carrier
  • 相关文献

参考文献11

  • 1Yoon Yeo,Kinam Park.Control of encapsulation efficiency and initial burst in polymeric microparticle systems[J].Archives of Pharmacal Research.2004(1)
  • 2Ho M L,Fu Y C,Wang G J,et al.Controlled release carrier ofBSA made by W/O/W emulsion method containing PLGA andhydroxyapatite[].Journal of Controlled Release.2008
  • 3Sharif S,O′Hagan D T.A comparison of alternative methods forthe determination of the levels of proteins entrapped in poly(lactide-co-glycolide)microparticles[].International Journal of Pharmaceutics.1995
  • 4Mao S,Shi Y,Li L,et al.Effects of process and formulationparameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide)microspheres formed by the solventevaporation method[].European Journal of Pharmaceutics and Biopharmaceutics.2008
  • 5Yang Y Y,Chung T S,Ng N P.Morphology,drug distribution,and in vitro release profiles of biodegradable polymericmicrospheres containing protein fabricated by double-emulsionsolvent extraction/evaporation method[].Biomaterials.2001
  • 6Petruska JC,Mendell LM.The many functions of nerve growth factor: multiple actions on nociceptors[].Neuroscience Letters.2004
  • 7SINGH L,KUMAR V,RATNER B D.Generation of porousmicrocellular 85/15poly(DL-lactide-co-glycolide)foams forbiomedical applications[].Biomaterials.2004
  • 8Yeo Y,Park K.Control of encapsulation efficiency and initial burst in polymeric microparticle systems[].Archives of Pharmacal Research.2004
  • 9Allison SD.Analysis of initial burst in PLGA microparticles[].Expert Opin Drug Deliv.2008
  • 10Fuminori Ito,Hiroyuki F,Kimiko M.Incorporation of water-soluble drugs in PLGA microspheres[].Colloids and Surfaces B Bio inter faces.2007

同被引文献87

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部